Skip to content
MS
rate-limiting unreviewed

Succinyl-CoA:3-ketoacid CoA transferase (SCOT / OXCT1)

1 reactions · 1 pathways

Clinical / pharmacological. SCOT deficiency: ketoacidosis; absent in liver, which is why liver cannot use ketones

What it does, reaction by reaction

1 reactions

Ketolysis (Ketone Body Utilization) Lipid Metabolism · Mitochondrial matrix

step 2 Irreversible/directional

Acetoacetate + succinyl-CoA → acetoacetyl-CoA + succinate

Converts Acetoacetate Succinyl-CoA into Acetoacetyl-CoA Succinate

Notes

Succinyl-CoA:3-ketoacid CoA transferase (SCOT; 3-oxoacid CoA-transferase, OXCT1) activates acetoacetate by transferring CoA from succinyl-CoA. This is the committed, functionally rate-determining step of ketone-body utilization; it bypasses succinyl-CoA synthetase and therefore sacrifices the GTP that would otherwise be generated in the TCA cycle. Liver lacks SCOT, preventing futile cycling.

Showing all 1 reactions.

What accelerates and inhibits it

Regulation is pathway-specific, so each context is listed separately

0 entries

No regulation recorded for this enzyme in the source documents.

Recent literature

Nothing is fetched until you ask, so the page stays fast and the request is yours rather than automatic.

Europe PMC · ten most recent, newest first